Johnson Matthey Receives Buy Rating from Liberum Capital (JMAT)
Johnson Matthey (LON:JMAT)‘s stock had its “buy” rating restated by stock analysts at Liberum Capital in a report issued on Friday, American Banking & Market News reports. They currently have a GBX 3,500 ($57.67) target price on the stock. Liberum Capital’s price objective suggests a potential upside of 8.33% from the stock’s previous close.
JMAT has been the subject of a number of other recent research reports. Analysts at BNP Paribas reiterated an “outperform” rating on shares of Johnson Matthey in a research note to investors on Friday. They now have a GBX 3,500 ($57.67) price target on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Johnson Matthey in a research note to investors on Friday. They now have a GBX 3,650 ($60.14) price target on the stock. Finally, analysts at Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,800 ($46.14) to GBX 2,900 ($47.78) in a research note to investors on Tuesday. They now have a “hold” rating on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 3,225.73 ($53.15).
Johnson Matthey (LON:JMAT) opened at 3231.0002 on Friday. Johnson Matthey has a one year low of GBX 2193.00 and a one year high of GBX 3452.00. The stock has a 50-day moving average of GBX 3284.08 and a 200-day moving average of GBX 3017.93. The company’s market cap is £6.551 billion.
Johnson Matthey Plc is a global specialty chemicals company operating in three divisions: Environmental Technologies, Precious Metal Products and Fine Chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.